Caribou Bioscience, Inc (CRBU)
1.57
0.00 (0.00%)
Upcoming Events
Latest Headlines
Caribou Biosciences Inc. (CRBU) PT Lowered to $5 at BofA Securities
August 14, 2026 5:19 AM - StreetInsider
Form 10-Q Caribou Biosciences, For: Jun 30
August 13, 2026 4:13 PM - SEC Filing
Form 8-K Caribou Biosciences, For: Aug 13
August 13, 2026 4:10 PM - SEC Filing
Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c
August 13, 2026 4:09 PM - StreetInsider
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026 4:06 PM - Globe NewsWire
Form SCHEDULE 13G Caribou Biosciences, Filed by: BlackRock, Inc.
July 27, 2026 4:28 PM - SEC Filing
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 29, 2026 8:00 AM - Globe NewsWire
Form 8-K Caribou Biosciences, For: Jun 17
June 18, 2026 4:02 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)
June 16, 2026 6:48 AM - StreetInsider
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
June 12, 2026 8:10 AM - StreetInsider
Form 8-K Caribou Biosciences, For: Jun 11
June 11, 2026 8:03 AM - SEC Filing
Caribou reports long-term data for vispa-cel in lymphoma patients
June 11, 2026 8:02 AM - StreetInsider
Caribou Biosciences reports durable responses for CB-011 therapy
June 11, 2026 8:01 AM - StreetInsider
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
June 11, 2026 8:01 AM - Globe NewsWire
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
June 11, 2026 8:00 AM - Globe NewsWire
Full Article List
